Unknown

Dataset Information

0

A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.


ABSTRACT: Purpose: While stereotactic body radiotherapy (SBRT) can reduce tumor volumes in patients with metastatic renal cell carcinoma (mRCC), little is known regarding the immunomodulatory effects of high-dose radiation in the tumor microenvironment. The main objectives of this pilot study were to assess the safety and feasibility of nephrectomy following SBRT treatment of patients with mRCC and analyze the immunological impact of high-dose radiation.Experimental Design: Human RCC cell lines were irradiated and evaluated for immunomodulation. In a single-arm feasibility study, patients with mRCC were treated with 15 Gray SBRT at the primary lesion in a single fraction followed 4 weeks later by cytoreductive nephrectomy. RCC specimens were analyzed for tumor-associated antigen (TAA) expression and T-cell infiltration. The trial has reached accrual (ClinicalTrials.gov identifier: NCT01892930).Results: RCC cells treated in vitro with radiation had increased TAA expression compared with untreated tumor cells. Fourteen patients received SBRT followed by surgery, and treatment was well-tolerated. SBRT-treated tumors had increased expression of the immunomodulatory molecule calreticulin and TAA (CA9, 5T4, NY-ESO-1, and MUC-1). Ki67+ -proliferating CD8+ T cells and FOXP3+ cells were increased in SBRT-treated patient specimens in tumors and at the tumor-stromal interface compared with archived patient specimens.Conclusions: It is feasible to perform nephrectomy following SBRT with acceptable toxicity. Following SBRT, patient RCC tumors have increased expression of calreticulin, TAA, as well as a higher percentage of proliferating T cells compared with archived RCC tumors. Collectively, these studies provide evidence of immunomodulation following SBRT in mRCC. Clin Cancer Res; 23(17); 5055-65. ©2017 AACR.

SUBMITTER: Singh AK 

PROVIDER: S-EPMC5581708 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.

Singh Anurag K AK   Winslow Timothy B TB   Kermany Mohammad Habiby MH   Goritz Vincent V   Heit Lilia L   Miller Austin A   Hoffend Nicholas C NC   Stein Leighton C LC   Kumaraswamy Lalith K LK   Warren Graham W GW   Bshara Wiam W   Odunsi Kunle K   Matsuzaki Junko J   Abrams Scott I SI   Schwaab Thomas T   Muhitch Jason B JB  

Clinical cancer research : an official journal of the American Association for Cancer Research 20170619 17


<b>Purpose:</b> While stereotactic body radiotherapy (SBRT) can reduce tumor volumes in patients with metastatic renal cell carcinoma (mRCC), little is known regarding the immunomodulatory effects of high-dose radiation in the tumor microenvironment. The main objectives of this pilot study were to assess the safety and feasibility of nephrectomy following SBRT treatment of patients with mRCC and analyze the immunological impact of high-dose radiation.<b>Experimental Design:</b> Human RCC cell li  ...[more]

Similar Datasets

| S-EPMC8057358 | biostudies-literature
| S-EPMC8033221 | biostudies-literature
| S-EPMC8418257 | biostudies-literature
| S-EPMC6403966 | biostudies-literature
| S-EPMC7406342 | biostudies-literature
| S-EPMC5385451 | biostudies-other
| S-EPMC5633591 | biostudies-literature
| S-EPMC7029802 | biostudies-literature
| S-EPMC7751973 | biostudies-literature
| S-EPMC9187610 | biostudies-literature